4-(2-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)acetamido)phenyl-3-(nitrooxy)propionate

ID: ALA4281901

PubChem CID: 145982218

Max Phase: Preclinical

Molecular Formula: C18H15N3O9S

Molecular Weight: 449.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)c2ccccc2S1(=O)=O)Nc1ccc(OC(=O)CCO[N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C18H15N3O9S/c22-16(11-20-18(24)14-3-1-2-4-15(14)31(20,27)28)19-12-5-7-13(8-6-12)30-17(23)9-10-29-21(25)26/h1-8H,9-11H2,(H,19,22)

Standard InChI Key:  ARUZCDMXRQVPMH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   29.1740   -4.5834    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.9912   -4.5831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4000   -5.2907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.3996   -3.8753    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5594   -2.4062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5636   -3.2234    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.2692   -2.8112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3747   -3.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3736   -4.3029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0816   -4.7118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0798   -3.0745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7884   -3.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7887   -4.2984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5674   -4.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0484   -3.8886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8201   -5.3282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8656   -3.8879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2736   -3.1799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0907   -3.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8643   -2.4725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5000   -3.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0888   -4.5907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4973   -5.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3154   -5.2973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7232   -4.5843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3123   -3.8804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7255   -6.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5427   -6.0024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9529   -6.7092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9497   -5.2938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7669   -5.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  6  5  2  0
  7  6  2  0
  8  9  2  0
  9 10  1  0
 10 13  2  0
 12 11  2  0
 11  8  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15  6  1  0
  6 12  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31  1  1  0
M  CHG  2   2   1   3  -1
M  END

Alternative Forms

  1. Parent:

    ALA4281901

    ---

Associated Targets(Human)

HepaRG (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.40Molecular Weight (Monoisotopic): 449.0529AlogP: 0.97#Rotatable Bonds: 8
Polar Surface Area: 162.22Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.82CX Basic pKa: CX LogP: 1.31CX LogD: 1.31
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.27Np Likeness Score: -1.60

References

1. Das M, Bhattacharjee S, Fronczek FR, Bazan NG, Trudell ML..  (2018)  Synthesis, hepatotoxic evaluation and antipyretic activity of nitrate ester analogs of the acetaminophen derivative SCP-1.,  28  (23-24): [PMID:30327145] [10.1016/j.bmcl.2018.09.020]

Source